Published in Maturitas on September 01, 1978
Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J (1980) 1.99
Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br Med J (1980) 1.24
Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality. Menopause (2013) 1.00
Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium. Br Med J (Clin Res Ed) (1983) 0.86
[The climacteric--physiology or pathology?]. Arch Gynecol Obstet (1989) 0.75
Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol (1983) 1.45
The menopause: benefits and risks of estrogen-progestogen replacement therapy. Fertil Steril (1982) 1.34
Leiomyoma of the bladder: case report and review of the literature. Int J Fertil (1989) 1.22
Use of the progestogen challenge test to reduce the risk of endometrial cancer. Obstet Gynecol (1980) 1.06
Prevention of endometrial cancer with progestogens. Maturitas (1986) 1.00
Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review. Am J Obstet Gynecol (1983) 0.97
Post-pill and pill-related amenorrhea-galactorrhea. Am J Obstet Gynecol (1971) 0.95
The role of hormones in the etiology and prevention of endometrial cancer. Clin Obstet Gynaecol (1986) 0.92
The relationship between breast cancer survival and prior postmenopausal estrogen use. Obstet Gynecol (1992) 0.92
Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens. J Am Geriatr Soc (1979) 0.91
The menopause. Invest Radiol (1986) 0.83
Serum gonadotropin levels and ancillary studies in Stein-Leventhal syndrome treated with clomiphene citrate. Obstet Gynecol (1971) 0.82
Inappropriate secretion of LH in the Stein-Leventhal syndrome. Obstet Gynecol (1973) 0.82
The protective role of progesterone in the prevention of endometrial cancer. Pathol Res Pract (1982) 0.81
Estrogen therapy and breast cancer in postmenopausal women. J Am Geriatr Soc (1980) 0.81
Arrhenoblastoma: three case reports. Obstet Gynecol (1972) 0.81
Antepartum pituitary infarction. Obstet Gynecol (1979) 0.80
Use of progestogen therapy. Am J Obstet Gynecol (1987) 0.80
Use of medroxyprogesterone acetate to prevent menopausal symptoms. Obstet Gynecol (1975) 0.80
Management of postmenopausal bleeding to prevent endometrial cancer. Maturitas (1978) 0.79
Proposal to decrease the risk and improve the prognosis of breast cancer. Am J Obstet Gynecol (1984) 0.79
Immediate postpartum oral contraception. Obstet Gynecol (1970) 0.79
Changes in thyroid function tests during danazol therapy. Obstet Gynecol (1980) 0.78
Role of progestogens in the prevention of breast cancer. Maturitas (1986) 0.77
Amenorrhea secondary to voluntary weight loss. South Med J (1979) 0.77
Estrogens, progestogens and endometrial cancer. J Reprod Med (1977) 0.77
Estrogen replacement therapy in women with previous breast cancer. Am J Obstet Gynecol (1999) 0.77
Hormones in the etiology and prevention of breast and endometrial cancer. South Med J (1984) 0.76
Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy. Obstet Gynecol (1993) 0.75
Re: "Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy". Am J Epidemiol (1990) 0.75
Mammographic screening. JAMA (1994) 0.75
Combined continuous hormone replacement therapy: a critical review. Obstet Gynecol (1995) 0.75
Oral contraceptives, postmenopausal oestrogen-progestagen use and breast cancer. J Obstet Gynaecol (Lahore) (1984) 0.75
Changes in sexual drives of patients on oral contraceptives. J Reprod Med (1976) 0.75
Sex steroids and cancer. Obstet Gynecol Clin North Am (1987) 0.75
Postmenopausal bleeding. J Am Geriatr Soc (1974) 0.75
Oestrogen-replacement therapy. Lancet (1979) 0.75
The role of hormones in endometrial cancer. South Med J (1978) 0.75
Evidence supports estrogen-progestogen replacement therapy. Postgrad Med (1985) 0.75
James Grant Thompson Memorial Lecture. Osteoporosis: benefits and risks of estrogen-progestogen replacement therapy. J Miss State Med Assoc (1986) 0.75
Symptomatic endometriosis in teen-agers. A reappraisal. Obstet Gynecol (1974) 0.75
Postmenopausal bleeding. Clin Obstet Gynaecol (1977) 0.75
Regression of Polycystic Ovaries by Estrogen Therapy. Obstet Gynecol (1976) 0.75
Oestrogen replacement therapy. Lancet (1979) 0.75
Hormone therapy for the menopause. Geriatrics (1981) 0.75
Benefits and risks of estrogen replacement therapy in the menopause. Del Med J (1984) 0.75
The adolescent gynecologic patient and her problems. Clin Obstet Gynecol (1979) 0.75
Role of hormones in the etiology and prevention of endometrial and breast cancer. Acta Obstet Gynecol Scand Suppl (1981) 0.75
The role of hormones in the etiology of breast and endometrial cancer. Acta Obstet Gynecol Scand Suppl (1979) 0.75
Clinical use of progestins in the menopausal patient: dosage and duration. J Reprod Med (1982) 0.75
Cancer and the use of estrogens. Int J Fertil (1986) 0.75
The "red queen" and endometrial hyperplasia. Fertil Steril (1994) 0.75
Estrogen-progestogen therapy during menopause. Renewed interest in the 1980s. Postgrad Med (1986) 0.75
A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group. Prog Clin Biol Res (1990) 0.75
Complete and partial vaginal agenesis. J Reprod Med (1979) 0.75
Breast cancer and oral contraceptive therapy in premenopausal women. J Reprod Med (1979) 0.75
Method of delivery in patients with uterine scar. South Med J (1967) 0.75